{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:05:34Z","timestamp":1790841934530,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60596-6","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:28:10Z","timestamp":1783009690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating machine learning and structure-based simulations to prioritise Z4P as a mutation-resilient IRE1\u03b1 inhibitor for breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Nithisha L.","family":"Bastin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. K.","family":"Praveen Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baranitharan","family":"Ethiraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"Rajarathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Shrihari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Sivanraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"60596_CR1","doi-asserted-by":"publisher","first-page":"1622954","DOI":"10.3389\/fpubh.2025.1622954","volume":"13","author":"O Freihat","year":"2025","unstructured":"Freihat, O., Sipos, D. & Kovacs, A. Global burden and projections of breast cancer incidence and mortality to 2050: a comprehensive analysis of GLOBOCAN data. Front. Public. Health. 13, 1622954. https:\/\/doi.org\/10.3389\/fpubh.2025.1622954 (2025).","journal-title":"Front. Public. Health"},{"key":"60596_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752. https:\/\/doi.org\/10.1038\/35021093 (2000).","journal-title":"Nature"},{"key":"60596_CR3","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc. Natl. Acad. Sci. U S A. 98, 10869\u201310874. https:\/\/doi.org\/10.1073\/pnas.191367098 (2001).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"60596_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon, D. J. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl. J. Med. 344, 783\u2013792. https:\/\/doi.org\/10.1056\/NEJM200103153441101 (2001).","journal-title":"N Engl. J. Med."},{"key":"60596_CR5","doi-asserted-by":"publisher","unstructured":"Hariharan, J. et al. Enzyme inhibitors for breast cancer therapy. In Frontiers in Enzyme Inhibition, 204\u2013227 https:\/\/doi.org\/10.2174\/9789811460821120010013 (Bentham Science, 2020).","DOI":"10.2174\/9789811460821120010013"},{"key":"60596_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E. & Gianni, L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 13, 674\u2013690. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"60596_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mrfmmm.2004.06.056","volume":"569","author":"M Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der, M. & Kaufman, R. J. ER stress and the unfolded protein response. Mutat. Res. 569, 29\u201363. https:\/\/doi.org\/10.1016\/j.mrfmmm.2004.06.056 (2005).","journal-title":"Mutat. Res."},{"key":"60596_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-030-67696-4_3","volume":"59","author":"BM Adams","year":"2021","unstructured":"Adams, B. M., Canniff, N. P., Guay, K. P. & Hebert, D. N. The role of endoplasmic reticulum chaperones in protein folding and quality control. Prog Mol. Subcell. Biol. 59, 27\u201350. https:\/\/doi.org\/10.1007\/978-3-030-67696-4_3 (2021).","journal-title":"Prog Mol. Subcell. Biol."},{"key":"60596_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell. Biol. 13, 89\u2013102. https:\/\/doi.org\/10.1038\/nrm3270 (2012).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"60596_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1126\/science.1209038","volume":"334","author":"P Walter","year":"2011","unstructured":"Walter, P. & Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081\u20131086. https:\/\/doi.org\/10.1126\/science.1209038 (2011).","journal-title":"Science"},{"key":"60596_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/415092a","volume":"415","author":"M Calfon","year":"2002","unstructured":"Calfon, M. et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing XBP-1 mRNA. Nature 415, 92\u201396. https:\/\/doi.org\/10.1038\/415092a (2002).","journal-title":"Nature"},{"key":"60596_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccr.2014.03.015","volume":"25","author":"HJ Clarke","year":"2014","unstructured":"Clarke, H. J., Chambers, J. E., Liniker, E. & Marciniak, S. J. Endoplasmic reticulum stress in malignancy. Cancer Cell. 25, 563\u2013573. https:\/\/doi.org\/10.1016\/j.ccr.2014.03.015 (2014).","journal-title":"Cancer Cell."},{"key":"60596_CR13","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1158\/0008-5472.CAN-04-1606","volume":"64","author":"L Romero-Ramirez","year":"2004","unstructured":"Romero-Ramirez, L. et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 64, 5943\u20135947. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1606 (2004).","journal-title":"Cancer Res."},{"key":"60596_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature13119","volume":"508","author":"X Chen","year":"2014","unstructured":"Chen, X. et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1\u03b1 pathway. Nature 508, 103\u2013107. https:\/\/doi.org\/10.1038\/nature13119 (2014).","journal-title":"Nature"},{"key":"60596_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2016.12.004","volume":"168","author":"JR Cubillos-Ruiz","year":"2017","unstructured":"Cubillos-Ruiz, J. R., Bettigole, S. E. & Glimcher, L. H. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell 168, 692\u2013706. https:\/\/doi.org\/10.1016\/j.cell.2016.12.004 (2017).","journal-title":"Cell"},{"key":"60596_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz, C. & Papa, F. R. The unfolded protein response and cell fate control. Mol. Cell. 69, 169\u2013181. https:\/\/doi.org\/10.1016\/j.molcel.2017.06.017 (2018).","journal-title":"Mol. Cell."},{"key":"60596_CR17","doi-asserted-by":"publisher","first-page":"E869","DOI":"10.1073\/pnas.1115623109","volume":"109","author":"BC Cross","year":"2012","unstructured":"Cross, B. C. et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc. Natl. Acad. Sci. U S A. 109, E869\u2013E878. https:\/\/doi.org\/10.1073\/pnas.1115623109 (2012).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"60596_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1182\/blood-2010-08-303099","volume":"117","author":"I Papandreou","year":"2011","unstructured":"Papandreou, I. et al. Identification of an IRE1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood 117, 1311\u20131314. https:\/\/doi.org\/10.1182\/blood-2010-08-303099 (2011).","journal-title":"Blood"},{"key":"60596_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cell.2014.07.002","volume":"158","author":"R Ghosh","year":"2014","unstructured":"Ghosh, R. et al. Allosteric inhibition of the IRE1\u03b1 RNase preserves cell viability and function during endoplasmic reticulum stress. Cell 158, 534\u2013548. https:\/\/doi.org\/10.1016\/j.cell.2014.07.002 (2014).","journal-title":"Cell"},{"issue":"12","key":"60596_CR20","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1021\/acschembio.0c00802","volume":"15","author":"D Korovesis","year":"2020","unstructured":"Korovesis, D., Rufo, N., Derua, R., Agostinis, P. & Verhelst, S. H. Kinase photoaffinity labeling reveals low selectivity profile of the IRE1 targeting imidazopyrazine-based KIRA6 inhibitor. ACS Chem. Biol. 15 (12), 3106\u20133111. https:\/\/doi.org\/10.1021\/acschembio.0c00802 (2020).","journal-title":"ACS Chem. Biol."},{"key":"60596_CR21","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1038\/s41467-018-05763-8","volume":"9","author":"SE Logue","year":"2018","unstructured":"Logue, S. E. et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat. Commun. 9, 3267. https:\/\/doi.org\/10.1038\/s41467-018-05763-8 (2018).","journal-title":"Nat. Commun."},{"key":"60596_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.trecan.2020.07.006","volume":"6","author":"DP Raymundo","year":"2020","unstructured":"Raymundo, D. P. et al. Pharmacological targeting of IRE1 in cancer. Trends Cancer. 6, 1018\u20131030. https:\/\/doi.org\/10.1016\/j.trecan.2020.07.006 (2020).","journal-title":"Trends Cancer"},{"key":"60596_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"JA DiMasi","year":"2016","unstructured":"DiMasi, J. A., Grabowski, H. G. & Hansen, R. W. Innovation in the pharmaceutical industry: new estimates of R&D costs. J. Health Econ. 47, 20\u201333. https:\/\/doi.org\/10.1016\/j.jhealeco.2016.01.012 (2016).","journal-title":"J. Health Econ."},{"key":"60596_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cell.2007.10.057","volume":"132","author":"KP Lee","year":"2008","unstructured":"Lee, K. P. et al. Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation in nonconventional RNA splicing. Cell 132, 89\u2013100. https:\/\/doi.org\/10.1016\/j.cell.2007.10.057 (2008).","journal-title":"Cell"},{"key":"60596_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"XY Meng","year":"2011","unstructured":"Meng, X. Y., Zhang, H. X., Mezei, M. & Cui, M. Molecular docking: a powerful approach for structure-based drug discovery. Curr. Comput. Aided Drug Des. 7, 146\u2013157. https:\/\/doi.org\/10.2174\/157340911795677602 (2011).","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"60596_CR26","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth, S. A. & Dror, R. O. Molecular dynamics simulation for all. Neuron 99, 1129\u20131143. https:\/\/doi.org\/10.1016\/j.neuron.2018.08.011 (2018).","journal-title":"Neuron"},{"key":"60596_CR27","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","volume":"23","author":"H Chen","year":"2018","unstructured":"Chen, H., Engkvist, O., Wang, Y., Olivecrona, M. & Blaschke, T. The rise of deep learning in drug discovery. Drug Discov Today. 23, 1241\u20131250. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.039 (2018).","journal-title":"Drug Discov Today"},{"key":"60596_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s42256-020-00236-4","volume":"2","author":"J Jim\u00e9nez-Luna","year":"2020","unstructured":"Jim\u00e9nez-Luna, J., Grisoni, F. & Schneider, G. Drug discovery with explainable artificial intelligence. Nat. Mach. Intell. 2, 573\u2013584. https:\/\/doi.org\/10.1038\/s42256-020-00236-4 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"60596_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan, S. & Olson, A. J. Small-molecule library screening by docking with PyRx. Methods Mol. Biol. 1263, 243\u2013250. https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19 (2015).","journal-title":"Methods Mol. Biol."},{"key":"60596_CR30","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes, S. A. et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 45, D777\u2013D783. https:\/\/doi.org\/10.1093\/nar\/gkw1121 (2017).","journal-title":"Nucleic Acids Res."},{"key":"60596_CR31","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427 (2018).","journal-title":"Nucleic Acids Res."},{"key":"60596_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13065-024-01178-3","volume":"18","author":"C Hayat","year":"2024","unstructured":"Hayat, C. et al. Identification of new potent NLRP3 inhibitors by multi-level in-silico approaches. BMC Chem. 18, 76. https:\/\/doi.org\/10.1186\/s13065-024-01178-3 (2024).","journal-title":"BMC Chem."},{"issue":"1","key":"60596_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s40203-025-00531-1","volume":"14","author":"C Hayat","year":"2026","unstructured":"Hayat, C. et al. Machine learning-guided discovery of mitogen-activated protein kinase 7 (MAPK7 inhibitors): integrating virtual screening, docking, and molecular dynamics simulations. Silico Pharmacol. 14 (1), 24. https:\/\/doi.org\/10.1007\/s40203-025-00531-1 (2026).","journal-title":"Silico Pharmacol."},{"key":"60596_CR34","doi-asserted-by":"publisher","first-page":"126467","DOI":"10.1016\/j.molliq.2024.126467","volume":"416","author":"C Hayat","year":"2024","unstructured":"Hayat, C. et al. Elucidating the interactions of advanced glycation end products with RAGE, employing molecular docking and MD simulation approaches: Implications of potent therapeutic for diabetes and its related complications. J. Mol. Liq. 416, 126467. https:\/\/doi.org\/10.1016\/j.molliq.2024.126467 (2024).","journal-title":"J. Mol. Liq."},{"key":"60596_CR35","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"60596_CR36","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee, P., Kemmler, E., Dunkel, M., Preissner, R. & ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 52, W513\u2013W520. https:\/\/doi.org\/10.1093\/nar\/gkae303 (2024).","journal-title":"Nucleic Acids Res."},{"key":"60596_CR37","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s00204-020-02784-5","volume":"94","author":"MN Jacobs","year":"2020","unstructured":"Jacobs, M. N. et al. Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens. Arch. Toxicol. 94, 2899\u20132923. https:\/\/doi.org\/10.1007\/s00204-020-02784-5 (2020).","journal-title":"Arch. Toxicol."},{"key":"60596_CR38","doi-asserted-by":"publisher","first-page":"47536","DOI":"10.1021\/acsomega.2c05693","volume":"7","author":"CN Cavasotto","year":"2022","unstructured":"Cavasotto, C. N. & Scardino, V. Machine learning toxicity prediction: latest advances by toxicity end point. ACS Omega. 7, 47536\u201347546. https:\/\/doi.org\/10.1021\/acsomega.2c05693 (2022).","journal-title":"ACS Omega"},{"key":"60596_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324 (2001).","journal-title":"Mach. Learn."},{"key":"60596_CR40","doi-asserted-by":"publisher","unstructured":"Chen, T. & Guestin, C. XGBoost: a scalable tree boosting system. In Proc. ACM SIGKDD Int. Conf. Knowl. Discov. Data Min. 785\u2013794 https:\/\/doi.org\/10.1145\/2939672.2939785 (2016).","DOI":"10.1145\/2939672.2939785"},{"key":"60596_CR41","doi-asserted-by":"publisher","unstructured":"Pisner, D. A. & Schnyer, D. M. Support vector machine. In Machine Learning, 101\u2013121 https:\/\/doi.org\/10.1016\/B978-0-12-815739-8.00006-7 (Academic Press, 2020).","DOI":"10.1016\/B978-0-12-815739-8.00006-7"},{"key":"60596_CR42","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1161\/CIRCULATIONAHA.106.68265","volume":"117","author":"MP LaValley","year":"2008","unstructured":"LaValley, M. P. Logistic regression. Circulation 117, 2395\u20132399. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.68265 (2008).","journal-title":"Circulation"},{"key":"60596_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.63454\/jbs20000018","volume":"1","author":"KPK Praveen","year":"2025","unstructured":"Praveen, K. P. K. Docking profiling and prediction of drug-targets. Glob J. Basic. Sci. 1, 1\u20135. https:\/\/doi.org\/10.63454\/jbs20000018 (2025).","journal-title":"Glob J. Basic. Sci."},{"key":"60596_CR44","first-page":"1279","volume":"29","author":"KPK Praveen","year":"2016","unstructured":"Praveen, K. P. K., Sivanandham, M. & Lavanya, D. silico binding analysis of withanolides with the human GM-CSFR. Pak J. Pharm. Sci. 29, 1279\u20131286 (2016).","journal-title":"Pak J. Pharm. Sci."},{"key":"60596_CR45","doi-asserted-by":"publisher","first-page":"100422","DOI":"10.1016\/j.imu.2020.100422","volume":"20","author":"PKP Krishnamoorthy","year":"2020","unstructured":"Krishnamoorthy, P. K. P. et al. In-silico study reveals immunological signaling pathways, their genes, and potential herbal drug targets in ovarian cancer. Inf. Med. Unlocked. 20, 100422. https:\/\/doi.org\/10.1016\/j.imu.2020.100422 (2020).","journal-title":"Inf. Med. Unlocked"},{"key":"60596_CR46","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256 (2009).","journal-title":"J. Comput. Chem."},{"key":"60596_CR47","first-page":"189","volume":"3","author":"J Karthick","year":"2013","unstructured":"Karthick, J., Kumar, P. K. & Loganathan, P. L. silico analysis of targeted drug delivery to hepatic cells using lipid nanoparticles to treat liver diseases. Asian J. Pharm. Technol. 3, 189\u2013194 (2013).","journal-title":"Asian J. Pharm. Technol."},{"key":"60596_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: high-performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132, 19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","journal-title":"SoftwareX"},{"key":"60596_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods. 14, 71\u201373. https:\/\/doi.org\/10.1038\/nmeth.4067 (2017).","journal-title":"Nat. Methods"},{"key":"60596_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1570180819666220805163725","volume":"20","author":"KPK Praveen","year":"2023","unstructured":"Praveen, K. P. K. et al. Molecular docking and simulation binding analysis of Boeravinone B with caspase-3 and EGFR of hepatocellular carcinoma. Lett. Drug Des. Discov. 20, 238\u2013244. https:\/\/doi.org\/10.2174\/1570180819666220805163725 (2023).","journal-title":"Lett. Drug Des. Discov"},{"key":"60596_CR51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/157018081966621122810310","volume":"19","author":"R Rekha","year":"2022","unstructured":"Rekha, R. et al. In silico studies of PARP1 and P2Y1 receptors as prospective targets of withaferin-A for cardiovascular diseases. Lett. Drug Des. Discov. 19, 323\u2013336. https:\/\/doi.org\/10.2174\/157018081966621122810310 (2022).","journal-title":"Lett. Drug Des. Discov"},{"key":"60596_CR52","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2174\/1386207323666200427114343","volume":"23","author":"KPK Praveen","year":"2020","unstructured":"Praveen, K. P. K. et al. T-cell epitope-based vaccine design against Nipah virus by reverse vaccinology approach. Comb. Chem. High. Throughput Screen. 23, 788\u2013796. https:\/\/doi.org\/10.2174\/1386207323666200427114343 (2020).","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"60596_CR53","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ndt\/gfae187","volume":"40","author":"NC Chesnaye","year":"2025","unstructured":"Chesnaye, N. C. et al. Non-linear relationships in clinical research. Nephrol. Dial Transpl. 40, 244\u2013254. https:\/\/doi.org\/10.1093\/ndt\/gfae187 (2025).","journal-title":"Nephrol. Dial Transpl."},{"key":"60596_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10822-022-00442-9","volume":"36","author":"R Rodr\u00edguez-P\u00e9rez","year":"2022","unstructured":"Rodr\u00edguez-P\u00e9rez, R. & Bajorath, J. Evolution of support vector machine and regression modeling in chemoinformatics and drug discovery. J. Comput. Aided Mol. Des. 36, 355\u2013367. https:\/\/doi.org\/10.1007\/s10822-022-00442-9 (2022).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"60596_CR55","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.7717\/peerj-cs.623","volume":"7","author":"D Chicco","year":"2021","unstructured":"Chicco, D., Warrens, M. J. & Jurman, G. The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation. PeerJ Comput. Sci. 7, e623. https:\/\/doi.org\/10.7717\/peerj-cs.623 (2021).","journal-title":"PeerJ Comput. Sci."},{"key":"60596_CR56","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1049\/cit2.70030","volume":"10","author":"Z Fan","year":"2025","unstructured":"Fan, Z. et al. P. Diverse models, united goal: a comprehensive survey of ensemble learning. CAAI Trans. Intell. Technol. 10, 959\u2013982. https:\/\/doi.org\/10.1049\/cit2.70030 (2025).","journal-title":"CAAI Trans. Intell. Technol."},{"key":"60596_CR57","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1002\/widm.1249","volume":"8","author":"O Sagi","year":"2018","unstructured":"Sagi, O. & Rokach, L. Ensemble learning: a survey. WIREs Data Min. Knowl. Discov. 8, e1249. https:\/\/doi.org\/10.1002\/widm.1249 (2018).","journal-title":"WIREs Data Min. Knowl. Discov"},{"key":"60596_CR58","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.dche.2022.100034","volume":"3","author":"M Barton","year":"2022","unstructured":"Barton, M. & Lennox, B. Model stacking to improve prediction and variable importance robustness for soft sensor development. Digit. Chem. Eng. 3, 100034. https:\/\/doi.org\/10.1016\/j.dche.2022.100034 (2022).","journal-title":"Digit. Chem. Eng."},{"key":"60596_CR59","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1038\/s41598-025-33495-5","volume":"16","author":"A \u00d6ter","year":"2026","unstructured":"\u00d6ter, A. et al. Stacking ensemble machine learning for predicting photodetector performance under varying illumination intensities. Sci. Rep. 16, 3600. https:\/\/doi.org\/10.1038\/s41598-025-33495-5 (2026).","journal-title":"Sci. Rep."},{"key":"60596_CR60","first-page":"1","volume":"7","author":"J Dem\u0161ar","year":"2006","unstructured":"Dem\u0161ar, J. Statistical comparisons of classifiers over multiple data sets. J. Mach. Learn. Res. 7, 1\u201330 (2006).","journal-title":"J. Mach. Learn. Res."},{"key":"60596_CR61","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1038\/s41598-024-56706-x","volume":"14","author":"O Rainio","year":"2024","unstructured":"Rainio, O., Teuho, J. & Kl\u00e9n, R. Evaluation metrics and statistical tests for machine learning. Sci. Rep. 14, 6086. https:\/\/doi.org\/10.1038\/s41598-024-56706-x (2024).","journal-title":"Sci. Rep."},{"key":"60596_CR62","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","volume":"187","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. IRE1\u03b1 silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell 187, 7248\u20137266. https:\/\/doi.org\/10.1016\/j.cell.2024.09.032 (2024).","journal-title":"Cell"},{"issue":"1","key":"60596_CR63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7324\/JABB.2023.110122","volume":"11","author":"A Anthappagudem","year":"2023","unstructured":"Anthappagudem, A., Enaganti, S. & Bhukya, B. Integration of mutational and molecular docking studies: An in silico approach to assess the stability and binding potential of CYP3A4. J. Appl. Biology Biotechnol. 11 (1), 161\u2013170. https:\/\/doi.org\/10.7324\/JABB.2023.110122 (2023).","journal-title":"J. Appl. Biology Biotechnol."},{"issue":"12","key":"60596_CR64","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1021\/acscentsci.8b00717","volume":"4","author":"M Aldeghi","year":"2018","unstructured":"Aldeghi, M., Gapsys, V. & de Groot, B. L. Accurate estimation of ligand binding affinity changes upon protein mutation. ACS Cent. Sci. 4 (12), 1708\u20131718. https:\/\/doi.org\/10.1021\/acscentsci.8b00717 (2018).","journal-title":"ACS Cent. Sci."},{"key":"60596_CR65","doi-asserted-by":"publisher","unstructured":"Prajapati, A. & Patel, H. Targeting p53\u2013MDM2 pathway with novel triazole\u2013oxazole hybrids: a fragment-based drug discovery approach for next-generation cancer therapies. Molecular Diversity. 1\u201319 https:\/\/doi.org\/10.1007\/s11030-025-11364-7 (2025).","DOI":"10.1007\/s11030-025-11364-7"},{"issue":"35","key":"60596_CR66","doi-asserted-by":"publisher","first-page":"e01564","DOI":"10.1002\/slct.202501564","volume":"10","author":"A Prajapati","year":"2025","unstructured":"Prajapati, A. et al. Computational Identification of Marine Natural Products as Potential MDM2 Inhibitors Using E-Pharmacophore\u2010Based Virtualand (2025). Screening, MD Simulations, MM\u2010GBSA, DFT, PCA. ChemistrySelect, 10(35), e01564 https:\/\/doi.org\/10.1002\/slct.202501564.","journal-title":"ChemistrySelect"},{"issue":"16","key":"60596_CR67","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/08927022.2025.2574641","volume":"51","author":"A Prajapati","year":"2025","unstructured":"Prajapati, A., Kachhadiya, R., Pravin, A., Singh, S. K. & Patel, H. Computational insights into marine-derived pVHL-HIF1\u03b1 inhibitors: pharmacophore modelling, molecular docking, MD simulations, MM\/PBSA and DFT studies. Mol. Simul. 51 (16), 1036\u20131053. https:\/\/doi.org\/10.1080\/08927022.2025.2574641 (2025).","journal-title":"Mol. Simul."},{"key":"60596_CR68","doi-asserted-by":"publisher","first-page":"106687","DOI":"10.1016\/j.isci.2023.106687","volume":"26","author":"DP Pelizzari-Raymundo","year":"2023","unstructured":"Pelizzari-Raymundo, D. P. et al. A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment. iScience 26, 106687. https:\/\/doi.org\/10.1016\/j.isci.2023.106687 (2023).","journal-title":"iScience"},{"key":"60596_CR69","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41401-022-00949-9","volume":"44","author":"KL Jiang","year":"2023","unstructured":"Jiang, K. L. et al. Discovery of toxoflavin, a potent IRE1\u03b1 inhibitor acting through structure-dependent oxidative inhibition. Acta Pharmacol. Sin. 44, 234\u2013243. https:\/\/doi.org\/10.1038\/s41401-022-00949-9 (2023).","journal-title":"Acta Pharmacol. Sin"},{"key":"60596_CR70","doi-asserted-by":"publisher","first-page":"1627133","DOI":"10.3389\/fimmu.2025.1627133","volume":"16","author":"Q Wu","year":"2025","unstructured":"Wu, Q. et al. EGR3 as a dual tumor-immune regulator: a machine learning-driven prognostic target for cold breast cancer. Front. Immunol. 16, 1627133. https:\/\/doi.org\/10.3389\/fimmu.2025.1627133 (2025).","journal-title":"Front. Immunol."},{"key":"60596_CR71","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1007\/s11030-024-11055-9","volume":"29","author":"R Jaiswal","year":"2025","unstructured":"Jaiswal, R., Bhati, G., Ahmed, S. & Siddiqi, M. I. iDCNNPred: an interpretable deep learning model for virtual screening and identification of PI3K\u03b1 inhibitors against triple-negative breast cancer. Mol. Divers. 29, 3077\u20133100. https:\/\/doi.org\/10.1007\/s11030-024-11055-9 (2025).","journal-title":"Mol. Divers."},{"key":"60596_CR72","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s11030-025-11119-4","volume":"29","author":"M Shahab","year":"2025","unstructured":"Shahab, M. et al. Machine learning-based screening and molecular simulations for discovering novel PARP-1 inhibitors targeting DNA repair mechanisms for breast cancer therapy. Mol. Divers. 29, 3323\u20133343. https:\/\/doi.org\/10.1007\/s11030-025-11119-4 (2025).","journal-title":"Mol. Divers."},{"key":"60596_CR73","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1007\/s12033-024-01328-x","volume":"67","author":"AA Zainulabidin","year":"2025","unstructured":"Zainulabidin, A. A., Sufyan, A. J. & Thirunavukkarasu, M. K. Triple-action therapy: combining machine learning, docking, and dynamics to combat BRCA1-mutated breast cancer. Mol. Biotechnol. 67, 4289\u20134304. https:\/\/doi.org\/10.1007\/s12033-024-01328-x (2025).","journal-title":"Mol. Biotechnol."},{"key":"60596_CR74","doi-asserted-by":"publisher","first-page":"25883","DOI":"10.1038\/s41598-025-11177-6","volume":"15","author":"A Hossam","year":"2025","unstructured":"Hossam, A. et al. Discovery of natural scaffolds as HER2 inhibitors for breast cancer: virtual screening, molecular dynamics, and biological characterization with selectivity profiling. Sci. Rep. 15, 25883. https:\/\/doi.org\/10.1038\/s41598-025-11177-6 (2025).","journal-title":"Sci. Rep."},{"key":"60596_CR75","doi-asserted-by":"publisher","first-page":"1505934","DOI":"10.3389\/fonc.2024.1505934","volume":"14","author":"L Li","year":"2024","unstructured":"Li, L. et al. Integration of machine learning and experimental validation to identify the prognostic signature related to diverse programmed cell deaths in breast cancer. Front. Oncol. 14, 1505934. https:\/\/doi.org\/10.3389\/fonc.2024.1505934 (2024).","journal-title":"Front. Oncol."},{"key":"60596_CR76","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1021\/acs.jcim.4c02122","volume":"65","author":"H Han","year":"2025","unstructured":"Han, H. et al. Employing automated machine learning (AutoML) methods to facilitate the in silico ADMET properties prediction. J. Chem. Inf. Model. 65, 3215\u20133225. https:\/\/doi.org\/10.1021\/acs.jcim.4c02122 (2025).","journal-title":"J. Chem. Inf. Model."},{"key":"60596_CR77","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nbt1206-1565","volume":"24","author":"WS Noble","year":"2006","unstructured":"Noble, W. S. What is a support vector machine? Nat. Biotechnol. 24, 1565\u20131567. https:\/\/doi.org\/10.1038\/nbt1206-1565 (2006).","journal-title":"Nat. Biotechnol."},{"key":"60596_CR78","first-page":"25","volume":"1","author":"DT Manallack","year":"2007","unstructured":"Manallack, D. T. The pKa distribution of drugs: application to drug discovery. Perspect. Med. Chem. 1, 25\u201338 (2007).","journal-title":"Perspect. Med. Chem."},{"key":"60596_CR79","doi-asserted-by":"crossref","unstructured":"Avdeef, A. Absorption and Drug Development: Solubility, Permeability, and Charge State (Wiley, 2012).","DOI":"10.1002\/9781118286067"},{"key":"60596_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A. et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv Rev. 46, 3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0 (2001).","journal-title":"Adv. Drug Deliv Rev."},{"key":"60596_CR81","unstructured":"Lundberg, S. M. & Lee, S. I. A unified approach to interpreting model predictions. In Adv Neural Inf. Process. Syst 30, 4765\u20134774 (2017)."},{"key":"60596_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","volume":"23","author":"A Galetin","year":"2024","unstructured":"Galetin, A. et al. Membrane transporters in drug development and as determinants of precision medicine. Nat. Rev. Drug Discov. 23, 255\u2013280. https:\/\/doi.org\/10.1038\/s41573-023-00877-1 (2024).","journal-title":"Nat. Rev. Drug Discov"},{"key":"60596_CR83","doi-asserted-by":"publisher","first-page":"45029","DOI":"10.1038\/s41598-025-28786-w","volume":"15","author":"C Yuan","year":"2025","unstructured":"Yuan, C. et al. A dynamic weighted ensemble learning framework for cardiovascular risk prediction in type 2 diabetes: a comparative study with SHAP-based interpretability. Sci. Rep. 15, 45029. https:\/\/doi.org\/10.1038\/s41598-025-28786-w (2025).","journal-title":"Sci. Rep."},{"key":"60596_CR84","doi-asserted-by":"publisher","first-page":"109370","DOI":"10.1016\/j.compeleceng.2024.109370","volume":"118","author":"Z Sadeghi","year":"2024","unstructured":"Sadeghi, Z. et al. A review of explainable artificial intelligence in healthcare. Comput. Electr. Eng. 118, 109370. https:\/\/doi.org\/10.1016\/j.compeleceng.2024.109370 (2024).","journal-title":"Comput. Electr. Eng."},{"issue":"5","key":"60596_CR85","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ph17050551","volume":"17","author":"A Ajmal","year":"2024","unstructured":"Ajmal, A. et al. Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches. Pharmaceuticals (Basel). 17 (5), 551. https:\/\/doi.org\/10.3390\/ph17050551 (2024).","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60596-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60596-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60596-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:51:16Z","timestamp":1790841076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60596-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60596"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60596-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30454"}}